PMV Pharmaceuticals, Inc. PMVP
1.25 USD -0.08 (-6.04%)
Nov 5, 2026, 11:15 AM EST
1.20 Day range 1.30
1.02 52-week range 1.91
- YTD
- -0.40%
- 1 year
- -4.96%
Financial health
Altman Z-Score
-6.24 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 4
Valuation
P/E -0.8×
FY 2018 5y median -2.2× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.6×
FY 2018 5y median 0.7× FY 2025
P/FCF -0.9×
FY 2018 5y median -2.6× FY 2025
EV/EBITDA -0.4×
FY 2018 5y median -1.8× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -112.1%
FY 2018 5y median -38.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -74.2%
FY 2018 5y median -30.6% FY 2025
ROIC -79.5%
FY 2018 5y median -33.5% FY 2025
ROA -66.7%
FY 2018 5y median -27.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -0.9%
FY 2018 FY 2025
EPS (diluted) -30.0%
FY 2018 FY 2025
Free Cash Flow -41.7%
FY 2018 FY 2025
Financial Health
Current Ratio 10.1×
FY 2018 5y median 14.8× FY 2025
Quick Ratio 10.1×
FY 2018 5y median 14.8× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31